Sub-clinical exposure to <i>Streptococcus pyogenes</i> drives the development of immunityAilin Lepletier, Manisha Pandey, Despena Vedis et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0
Subclinical exposure to Streptococcus pyogenes drives the development of long-lived immunityManisha Pandey, Ailin Lepletier, Joshua Osowicki et al.|Research Square|2025Cited by 0
Delineating Humoral and Cellular Immune Responses Induced by a Peptide-Based Vaccine for Protection Against Streptococcus pyogenesDespena Vedis, Manisha Pandey, Ailin Lepletier et al.|Unknown|2025Cited by 0
Low-Dose Interleukin-2 Therapy: A Transformative Approach for the Management of Autoimmune Complications Associated with Streptococcus pyogenes InfectionsAilin Lepletier, Manisha Pandey, Harshi Weerakoon et al.|Unknown|2025Cited by 0
Subclinical exposure to Streptococcus pyogenes drives the development of long-lived homologous immunityAilin Lepletier, Manisha Pandey, Despena Vedis et al.|Nature Communications|2026Cited by 0